For as long as we have been representing drug and device companies in product liability litigation, the plaintiffs have accused our clients of “buying the science.”  Sometimes, this has allegedly been by funding studies or offering support to outside researchers such as free product or access to administrative support.  Sometimes, this has allegedly been by…